OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
INNPF
Innocan Pharma Corp.
Ordinary Shares
12.51
0.00
0.00%
12.98 / 13.20 (200 x 100)
Real-Time Best Bid & Ask: 05:00pm 10/31/2025
Delayed (15 Min) Trade Data: 12:00am 10/16/2025
0.00
N/A
0
Market Cap calculated only for this class of securities.
56,279,638
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|---|---|---|
G1 Execution Services, LLC | 12.98 | 100 | 10/31 |
VIRTU Americas LLC | 12.98 | 100 | 10/31 |
StoneX Financial Inc. | 12.93 | 100 | 10/31 |
Virtu Americas LLC | 12.75 | 300 | 10/31 |
Citadel Securities | 9.00 | 100 | 10/31 |
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|---|---|---|
VIRTU Americas LLC | 13.20 | 100 | 10/31 |
Virtu Americas LLC | 13.21 | 300 | 10/31 |
G1 Execution Services, LLC | 13.21 | 100 | 10/31 |
StoneX Financial Inc. | 13.26 | 100 | 10/31 |
Citadel Securities | 17.16 | 100 | 10/31 |
Trade Data
Date Date | Timestamp Timestamp | Price Price | $ Change $ Change | Volume Volume |
|---|---|---|---|---|
| 10/16/2025 | 14:50:01 | 12.51 | -1.75 | 100 |
| 10/08/2025 | 11:14:16 | 14.26 | 0.10 | 100 |
| 10/08/2025 | 09:46:45 | 14.16 | 0.36 | 100 |
| 10/07/2025 | 14:48:50 | 13.80 | -0.16 | 100 |
| 10/07/2025 | 13:21:19 | 13.96 | -0.03 | 100 |
News
Innocan Pharma to Present at the 2025 ThinkEquity ConferenceCANADA NEWSWIRE | 10/24/2025
Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in JapanCANADA NEWSWIRE | 10/15/2025
Innocan Pharma Announces Details of Proposed Share ConsolidationCANADA NEWSWIRE | 08/29/2025
Filings and Disclosure
Company Description
The Corporation's business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.
Videos
This company has not added any videos
Venture Market
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
54.40
Change
1.52 (2.87%)
Bid
54.40
Ask
55.00
Volume
19777
Time
00:00
© 2025 OTC Markets Group Inc.
Terms of ServiceLinking TermsTrademarksPrivacy StatementCode of ConductRisk WarningSupported Browsers